Illumina shares rose after Medicare approved reimbursement for its FDA-approved cancer test, a move expected to drive growth.
Zacks.com on MSN
REGN vs. ILMN: Which Stock Is the Better Value Option?
But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. We have found that the best way to discover great value opportunities is ...
Zacks Investment Research on MSN
Here's why Illumina (ILMN) is a strong momentum stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results